CEO says the group sees no signs of significant delays or cancellations in demand from hyperscalers and data centres ...
Indian Trade Minister says a trade deal with the US will not compromise any sensitive interests of farmers or other stakeholders ...
Weekly rig counts are a supply-side slow signal rather than a price catalyst: the print moves WTI only in exceptional weeks, and the established pattern is that a modest week-on-week build of this ...
Some Japanese aluminium buyers agreed to pay global producers premiums of USD 255/tonne for October-December shipments, -35% Q/Q, sources say. The quarterly Japan premium is the region's benchmark for ...
Iran President Pezeshkian says Tehran will never shy away fro dialogue even as the US targeted Iran several times, reports ...
The conflict in the Middle East has created major uncertainty about growth, inflation and interest rates. But looking through a shock is possible only if inflation expectations remain well anchored.
Canadian PM Carney's office says Carney spoke with US President Trump and that Canada will maximize exports of oil and diesel to the US, with all exports to the US yielding over 1mln barrels of diesel ...
SNAPSHOT: Equities up, Treasuries steepened, Crude up, Dollar down, Gold up. REAR VIEW: US completes wave of attacks against Iranian military targets; Iran responded to US strikes on US air bases; ...
Revisions of this kind are a mechanical read-through of the finance ministry's underlying assumptions rather than new information: Russian budget revenue forecasts embed an assumed Urals price and a ...
CLOSES: Euro Stoxx 50 -0.83% at 6,268, Dax 40 -0.74% at 25,211, FTSE 100 -0.29% at 10,606, CAC 40 -0.89% at 7,965, FTSE MIB -0.84% at 51,372, IBEX 35 -0.45% at 19,431, PSI +0.01% at 9,667, SMI -0.66% ...
APAC stocks took impetus from the positive global risk sentiment and lower yield environment after Fed's Waller kept a September rate hold in play and following no major new geopolitical developments, ...
US equity futures trade lower as participants return from holiday; Novartis suffers after key drug misses primary endpoints. Read the whole note →Free to read. This headline was on the Newsquawk live ...